Glenview Capital Management
Multi-Strategy- Manager
- Glenview Capital Management
- Quarter
- Q2 2026
- Filed
- 2026-08-14
- 13F value
- $5.01B
- Positions
- 42
- CIK
- 0001138995
| # | # Shares | Source | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Global Pmts IncGPNHISTORY | 12.91% | +40.0% | $646.3M | 8,906,709 | +2,546,317 | — | 13F |
| 2 | CVS Health CorpCVSHISTORY | 9.97% | (41.1%) | $499.1M | 4,824,799 | (3,372,000) | 0.38% | 13F |
| 3 | Tenet Healthcare CorpTHCHISTORY | 8.35% | +46.6% | $418.2M | 2,235,666 | +710,812 | 2.78% | 13F |
| 4 | Thermo Fisher Scientific IncTMOHISTORY | 6.28% | +150.4% | $314.5M | 627,240 | +376,715 | 0.17% | 13F |
| 5 | Amazon Com IncAMZNHISTORY | 6.05% | +20.1% | $303.1M | 1,271,687 | +212,417 | 0.01% | 13F |
| 6 | Agilent Technologies IncAHISTORY | 5.23% | NEW | $261.6M | 1,969,541 | +1,969,541 | 0.70% | 13F |
| 7 | Danaher Corp DelDHRHISTORY | 4.36% | +633.3% | $218.3M | 1,145,979 | +989,704 | 0.16% | 13F |
| 8 | Meta Platforms IncMETAHISTORY | 4.02% | +190.9% | $201.0M | 356,841 | +234,179 | 0.01% | 13F |
| 9 | Advanced Micro Devices IncAMDHISTORY | 3.46% | (54.1%) | $173.3M | 298,410 | (352,382) | 0.02% | 13F |
| 10 | Teva Pharmaceutical Inds LTDTEVAHISTORY | 3.44% | (23.7%) | $172.1M | 5,081,091 | (1,579,129) | 0.44% | 13F |
| 11 | Viatris IncVTRSHISTORY | 3.13% | +8.7% | $156.9M | 9,877,409 | +790,165 | 0.86% | 13F |
| 12 | Uber Technologies IncUBERHISTORY | 2.59% | +23.2% | $129.4M | 1,793,598 | +337,726 | 0.09% | 13F |
| 13 | Centene Corp DelCNCHISTORY | 2.42% | (41.3%) | $121.1M | 1,886,055 | (1,327,591) | 0.38% | 13F |
| 14 | Butterfly Network IncBFLYHISTORY | 2.41% | — | $120.7M | 14,335,055 | — | 6.17% | 13F+13D |
| 15 | The Cigna GroupCIHISTORY | 2.27% | (17.4%) | $113.6M | 412,223 | (86,618) | 0.16% | 13F |
| 16 | Humana IncHUMHISTORY | 2.02% | (24.1%) | $101.0M | 254,216 | (80,676) | — | 13F |
| 17 | Block IncXYZHISTORY | 1.82% | (12.3%) | $91.0M | 1,197,046 | (167,425) | 0.20% | 13F |
| 18 | Dicks Sporting Goods IncDKSHISTORY | 1.82% | +34.2% | $91.0M | 401,067 | +102,156 | 0.45% | 13F |
| 19 | Genius Sports LimitedGENIHISTORY | 1.63% | +57.6% | $81.8M | 13,495,287 | +4,934,399 | 134.95% | 13F |
| 20 | Onto Innovation IncONTOHISTORY | 1.56% | (31.3%) | $77.9M | 205,791 | (93,930) | 0.42% | 13F |
| 21 | Eli Lilly & CoLLYHISTORY | 1.38% | NEW | $69.3M | 57,771 | +57,771 | 0.01% | 13F |
| 22 | United Airls Hldgs IncUALHISTORY | 1.34% | (0.4%) | $67.3M | 494,736 | (2,124) | — | 13F |
| 23 | National Vision Hldgs IncEYEHISTORY | 1.18% | +98.0% | $59.0M | 3,101,083 | +1,535,166 | 3.92% | 13F |
| 24 | Cisco Sys IncCSCOHISTORY | 0.97% | +21.6% | $48.5M | 413,332 | +73,513 | 0.01% | 13F |
| 25 | Element Solutions IncESIHISTORY | 0.95% | (38.9%) | $47.5M | 994,579 | (634,104) | — | 13F |
| 26 | Applied Matls IncAMATHISTORY | 0.94% | (66.9%) | $47.1M | 65,201 | (132,008) | 0.01% | 13F |
| 27 | MKS Inc.MKSIHISTORY | 0.88% | NEW | $43.8M | 98,532 | +98,532 | 0.15% | 13F |
| 28 | Six Flags Entertainment CorpFUNHISTORY | 0.86% | (9.2%) | $43.0M | 2,017,821 | (205,328) | 1.97% | 13F |
| 29 | Stmicroelectronics N VSTMHISTORY | 0.84% | NEW | $41.9M | 560,060 | +560,060 | 0.06% | 13F |
| 30 | Abbvie IncABBVHISTORY | 0.75% | NEW | $37.5M | 148,913 | +148,913 | 0.01% | 13F |
| 31 | Astrazeneca PLCAZNHISTORY | 0.70% | NEW | $34.9M | 184,279 | +184,279 | — | 13F |
| 32 | Bausch Plus Lomb CorpBLCOHISTORY | 0.63% | +0.4% | $31.8M | 1,918,148 | +7,652 | 0.54% | 13F |
| 33 | Baker Hughes CompanyBKRHISTORY | 0.55% | +62.5% | $27.4M | 493,519 | +189,844 | 0.05% | 13F |
| 34 | Elevance Health Inc FormerlyELVHISTORY | 0.51% | NEW | $25.8M | 66,599 | +66,599 | 0.03% | 13F |
| 35 | Microchip Technology Inc.MCHPHISTORY | 0.48% | NEW | $24.2M | 265,577 | +265,577 | 0.05% | 13F |
| 36 | Bruker CorpBRKRHISTORY | 0.30% | NEW | $15.2M | 252,169 | +252,169 | 0.17% | 13F |
| 37 | Novartis AGNVSHISTORY | 0.27% | NEW | $13.6M | 86,909 | +86,909 | 0.00% | 13F |
| 38 | Digitalocean Hldgs IncDOCNHISTORY | 0.27% | (66.1%) | $13.3M | 84,812 | (165,188) | 0.07% | 13F |
| 39 | Primo Brands CorporationPRMBHISTORY | 0.20% | (23.7%) | $9.9M | 404,971 | (126,080) | 0.11% | 13F |
| 40 | Boston Scientific CorpBSXHISTORY | 0.10% | NEW | $4.8M | 113,096 | +113,096 | 0.01% | 13F |
| 41 | Cardinal Health IncCAHHISTORY | 0.09% | NEW | $4.3M | 18,018 | +18,018 | 0.01% | 13F |
| 42 | Bio-Techne CorpTECHHISTORY | 0.08% | (68.7%) | $4.1M | 58,324 | (127,988) | 0.04% | 13F |
Positions are from the latest 13F-HR (period end 2026-06-30). Weights are calculated: position value ÷ the 13F book. Rows marked Off-13F are >5% stakes disclosed on a Schedule 13D/13G dated after the latest 13F; they report shares and percent of class but no dollar value. Chg Shares and % Chg compare with the adjacent prior quarter's 13F only. % Out is either calculated (position shares ÷ issuer shares outstanding from the issuer's XBRL cover page; weighted-average basic shares as a fallback) or reported (percent of class on a Schedule 13D/13G newer than the 13F period) — hover a value for its source and date. Unavailable figures show “—”, never an estimate. Methodology